Chemical Decapsulation of Artemia franciscana Resting Cysts Does Not Necessarily Produce More Nauplii

Decapsulation of Artemia spp. cysts in strong hypochlorite solutions reportedly increases the number of nauplii that hatch. Commercial cysts of Artemia franciscano were subjected to four decapsulation methods prior to hatching them in aerated seawater. Samples were removed from the hatch vessels every 5 h from 15 through 45 h, and fully hatched nauplii were counted. The experiment was performed three times. No significant difference was seen between mean numbers of control nauplii and nauplii obtained using the decapsulation method that yielded the best hatch: oxidation for 15 min in equal parts Clorox® and seawater plus 6 mL of a 40% NaOH solution, followed by reduction with 100 mL of 0.7 M sodium thiosulfate. A third treatment was inferior to either of these, and two others produced very low yields. It was concluded that of the methods evaluated, none is superior to no treatment at all, and some are clearly detrimental to developing Artemia embryos.     

Parenteral nutrition in neonatal foals: clinical description, complications and outcome in 53 foals (1995-2005)

This retrospective study describes the use of and complications associated with parenteral nutrition (PN) administration to 53 equine neonates at the University of California Veterinary Medical Teaching Hospital. Medical records were examined and information obtained on signalment, physical examination, clinical diagnosis, outcome, total hospitalization time, insulin administration, microbiology culture results, other complications (i.e. thrombophlebitis) and necropsy findings. Complete blood count and serum biochemistry analytes, venous blood gas, serum electrolyte and glucose concentrations, and blood lactate concentration results were compared before and during PN administration in all foals. Seventeen foals (32%) developed hypertriglyceridemia (>200mg/dL). Triglyceride concentrations >200mg/dL were significantly (P=0.049) associated with non-survival. Forty-seven foals (89%) developed hyperglycemia (blood glucose >120mg/dL) and eight (15%) developed catheter-related complications (thrombosis or local sepsis). Packed cell volume, total protein, creatinine, blood urea nitrogen, and sorbitol dehydrogenase concentrations decreased while foals were on PN, while serum chloride concentration increased. This study highlighted that hypertriglyceridemia during the acute phase of neonatal illness may be detrimental to outcome, and that the safety of lipid-containing solutions in foals warrants further study.     

Effect of Ergopeptines Associated with Tall Fescue Ingestion on Recovery of Horses Subjected to Standardized Exercise Tests

Ten horses were paired by body weight, age, and skill level, and one of each pair was assigned to one of two groups. Horses were fed alfalfa hay and a mixture of commercial sweet feed and pellets. Horses in group A were fed fescue seed that contained both ergovaline and ergotamine (E+), whereas those in the other group were fed seed that was free from ergot alkaloids (E−). After the first 35 days, horses were switched to the opposite seed treatment. Seed was fed at 8.2% of the diet, resulting in 406 ppb of ergotamine plus ergovaline in the E+ diet. During weeks 3, 5, 7, and 10, horses were subjected to two separate standardized exercise tests (SETs). The aerobic test consisted of walking, trotting, and loping and was designed to maintain horse's heart rate (HR) to less than 150 beats per minute (bpm). The anaerobic test consisted of 40 turns in less than 4 minutes in response to the movements of a mechanical cow and was designed to increase the horse's HR to more than 150 bpm. There were no treatment effects on water consumption or sweat production. There were also no treatment effects on rectal temperature at rest or during recovery from the anaerobic SET. However, rectal temperatures were higher (P < .05) 1 and 30 minutes after the aerobic SET for horses consuming E+ seed. When horses were on the E+ treatment, HRs were lower (P < .05), both at rest and during the SET. HRs were also lower (P < .05) for the E+ treatment at 1 minute after the aerobic test and 5 and 10 minutes after the anaerobic test. Respiration rates were higher (P < .05) 30 minutes after the aerobic SET and 30 and 60 minutes after the anaerobic SET for the E+ treatment. Horses may have increased respiration rates to compensate for a reduction in the efficiency of evaporative cooling, which resulted from vasoconstriction of peripheral blood vessels.     

Plasma pharmacokinetics of selamectin after a single topical administration in the American bullfrog (Rana catesbeiana).

Parasitism is common in wild and captive amphibians; however, pharmacologic data are lacking for anthelmintic drugs. This study was developed to determine the plasma pharmacokinetics of selamectin after topical administration in bullfrogs. Thirty-two adult American bullfrogs (Rana catesbeiana) were randomly assigned into eight groups of four with each group representing a different collection time point. Seven groups received selamectin (6 mg/ kg) topically and the remaining group served as the untreated control group. One group of frogs was euthanized and blood samples immediately collected on days 0 (control), 1, 5, 10, 15, 20, 25, and 30. Plasma was analyzed for selamectin using high performance liquid chromatography with fluorescence detection. Individual samples were analyzed, then data were reported as the mean of the four frogs at each time point. A histologic evaluation of the lung, liver, kidney, and skin tissues was performed and none of the frogs showed histologic evidence of toxicity due to selamectin administration. The mean peak plasma concentration was 162.5 +/- 42.3 ng/ml, area under the curve was 2,856 ng day/ml, mean residence time was 12.2 days, and disappearance half-life was 1.87 days. Based on the plasma pharmacokinetics, bullfrogs appear to absorb selamectin very efficiently, concentrations reach high levels in the plasma, and there were no apparent histologic effects from single dose administration.     

Myoplasmic calcium regulation in myotubes from horses with recurrent exertional rhabdomyolysis

OBJECTIVE: To determine whether alterations in myoplasmic calcium regulation can be identified in muscle cell cultures (myotubes) and intact muscle fiber bundles derived from Thoroughbreds affected with recurrent exertional rhabdomyolysis (RER). ANIMALS: 6 related Thoroughbreds with RER and 8 clinically normal (control) Thoroughbred or crossbred horses. PROCEDURES: Myotube cell cultures were grown from satellite cells obtained from muscle biopsy specimens of RER-affected and control horses. Fura-2 fluorescence was used to measure resting myoplasmic calcium concentration as well as caffeine- and 4-chloro-m-cresol (4-CMC)-induced increases in myoplasmic calcium. In addition, intact intercostal muscle fiber bundles were prepared from both types of horses, and their sensitivities to caffeine- and 4-CMC-induced contractures were determined. RESULTS: Myotubes of RER-affected and control horses had identical resting myoplasmic calcium concentrations. Myotubes from RER-affected horses had significantly higher myoplasmic calcium concentrations than myotubes from control horses following the addition of > or = 2mM caffeine; however, there was no difference in their response to 4-CMC (> or = 1 mM). Caffeine contracture thresholds for RER and control intact muscle cell bundles (2 vs 10mM, respectively) were significantly different, but 4-CMC contracture thresholds of muscle bundles from RER-affected and control horses (500 microM) did not differ. CONCLUSIONS AND CLINICAL RELEVANCE: An increase in caffeine sensitivity of muscle cells derived from a family of related RER-affected horses was detected in vitro by use of cell culture with calcium imaging and by use of fiber bundle contractility techniques. An alteration in muscle cell calcium regulation is a primary factor in the cause of this heritable myopathy.